ADMINISTRATIVE BUDGET: AIDS

行政预算:艾滋病

基本信息

  • 批准号:
    7720571
  • 负责人:
  • 金额:
    $ 22.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Regarding AIDS The Principal Investigator of the Program, Dr. Jos¿ R. Carlo-Izquierdo, Chancellor of the Medical Sciences Campus, has the responsibility of ensuring that program goals are met and that appropriate institutional support is provided to the program. All responsibilities of daily operations are delegated to the Program Director. The RCRII Program has a Director, an Associate Director, and an Assistant Director. The combined percentage of their effort provides 100% of a full time position. The Program Director, Dr. Julio E. Benabe, has a 40% time effort and oversees the entire program. He presides a weekly staff meeting where all issues concerning the daily activities of the RCRII are reviewed and discussed with the entire staff. The PD also attends the monthly meeting with the RCAC and reports to them the important issues related to new studies, development of established collaborations, and the links with the participating programs supported by the RCRII. As the Associate Chief of Staff for R&D at the VA Hospital, it is not possible for Dr. Benabe to be physically present in the unit at all times, however, the Associate Director, Dr. Carlos Luciano (35%), and the Assistant Director, Dr. Marcia Cruz (25%), allow for a constant presence of one of the Directors and assist the P.D. in all aspects of the operation of the program. The Associate Program Director serves as a liaison with the faculty and administrative mechanisms in the MSC, facilitating the implementation of the program's goals and specific aims within the institution. The Research Clinical Advisory Committee (RCAC) has an instrumental role in the directorship of the RCRII. The RCAC is composed of two subcommittees, an internal subcommittee composed of faculty and investigators from the UPR-MSC and an External Subcommittee composed of our external advisors Drs. Brater, Watkins, and Palefsky. The RCAC is responsible for approving all the protocols conducted at the RCRII, for the process of selection of the pilot projects, for the allocation of RCRII resources, and for overseeing the operation and the policies of the RCRII. It also provides advice to the P.I. and the PDs on scientific initiatives. The Internal Subcommittee of the RCAC meets on a monthly basis to review submitted protocols and the general direction of the RCRII. The committee evaluates each protocol using a standard format developed and approved by the committee to address all the relevant issues pertaining protocols at the RCRII. Each protocol is reviewed by two "primary" reviewers who are voting members of the committee and then are considered by the committee as a whole. Additional input from the biostatistician and the RSA is requested. The PD, Associate PD, and Assistant PD attend each of the RCAC monthly meetings as non-voting members. They discuss all matters pertaining to the daily activities at the RCRII, compliance with all the regulations to conduct clinical research in a federally funded program, review data and safety monitoring plans for all new protocols, and participate in the discussion and assessment of all new protocols applying for use of the RCRII facilities as well as in the proposed collaborations with other programs.
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 关于艾滋病 该计划的首席研究员、医学校园校长何塞·R·卡洛-伊兹奎尔多博士有责任确保实现计划目标,并为该计划提供适当的机构支持。日常运营的所有职责都委派给项目总监。 RCRII项目有一名主任、一名副主任和一名助理主任。他们努力的百分比加起来提供了100%的全职职位。项目主任胡里奥·E·贝纳贝博士有40%的时间,负责监督整个项目。他主持每周一次的工作人员会议,审查与RCRII日常活动有关的所有问题,并与全体工作人员讨论。PD还参加与RCAC的每月会议,并向他们报告与新研究、已建立的合作的发展以及与RCRII支持的参与计划的联系有关的重要问题。作为退伍军人事务部医院负责研发的副主任,Benabe博士不可能一直在单位内,然而,副主任Carlos Luciano博士(35%)和助理主任Marcia Cruz博士(25%)允许其中一名主任持续在场,并在项目运作的所有方面协助警察局。副项目主任作为与MSC的教职员工和行政机制的联络人,促进项目目标和具体目标在机构内的实施。 研究临床咨询委员会(RCAC)在RCRII的董事职位上发挥了重要作用。RCAC由两个小组委员会组成,一个内部小组委员会由UPR-MSC的教职员工和研究人员组成,另一个外部小组委员会由我们的外部顾问Brater、Watkins和Palefsky博士组成。RCAC负责批准在RCRII进行的所有议定书,负责选择试点项目,分配RCRII资源,并监督RCRII的运作和政策。它还为P.I.和PDS提供关于科学倡议的建议。区域合作与合作委员会内部小组委员会每月举行会议,审查所提交的议定书和区域合作与合作委员会第二次会议的总体方向。委员会使用委员会制定和批准的标准格式对每项议定书进行评价,以解决与RCRII的议定书有关的所有问题。每个议定书都由两名作为委员会有投票权的成员的“主要”审查员进行审查,然后由委员会作为一个整体进行审议。要求生物统计学家和RSA提供更多的信息。警署、协理警署和助理警署以无投票权成员身分出席每次区域反腐败委员会的月会。他们讨论与RCRII的日常活动有关的所有事项,遵守联邦资助计划中进行临床研究的所有规定,审查所有新方案的数据和安全监测计划,并参与所有申请使用RCRII设施的新方案的讨论和评估,以及与其他计划的拟议合作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jose R. Carlo其他文献

Jose R. Carlo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jose R. Carlo', 18)}}的其他基金

RCMI Multidisciplinary Collaborative Research Program
RCMI 多学科合作研究计划
  • 批准号:
    7920757
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
EFFECT SIZE FROM PTSD EXPOSURE THERAPY TRAIL
创伤后应激障碍 (PTSD) 暴​​露治疗轨迹的影响大小
  • 批准号:
    7959669
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
NEUROPROTECTIVES FOR HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS
针对 HIV 相关神经认知障碍的神经保护剂
  • 批准号:
    7959668
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
SPATIAL LEARNING - PILOT STUDY
空间学习 - 试点研究
  • 批准号:
    7959670
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
ADMINISTRATIVE BUDGET
行政预算
  • 批准号:
    7959666
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
GENETIC EPIDEMIOLOGY AND MOLECULAR PATHOLOGY OF COLORECTAL CANCER IN HISPANICS
西班牙裔结直肠癌的遗传流行病学和分子病理学
  • 批准号:
    7959667
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
RCMI MULTIDISCIPLINARY COLLABORATIVE RESEARCH PROGRAM - ADMINISTRATIVE COMPONENT
RCMI 多学科合作研究计划 - 管理部分
  • 批准号:
    7959192
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
RCMI Multidisciplinary Collaborative Research Program
RCMI 多学科合作研究计划
  • 批准号:
    7933229
  • 财政年份:
    2009
  • 资助金额:
    $ 22.43万
  • 项目类别:
RCMI MULTIDISCIPLINARY COLLABORATIVE RESEARCH PROGRAM - ADMINISTRATIVE COMPONENT
RCMI 多学科合作研究计划 - 管理部分
  • 批准号:
    7715295
  • 财政年份:
    2008
  • 资助金额:
    $ 22.43万
  • 项目类别:
GENES REGULATED BY TWIST2
受 TIST2 调控的基因
  • 批准号:
    7720573
  • 财政年份:
    2008
  • 资助金额:
    $ 22.43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了